FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912138085> ?p ?o ?g. }

• W2912138085 endingPage "514" @default.
• W2912138085 startingPage "514" @default.
• W2912138085 abstract "Approximately 50% of the risk for the development of testicular germ cell tumors (TGCTs) is estimated to be heritable, but no mendelian TGCT predisposition genes have yet been identified. It is hypothesized that inherited pathogenic DNA repair gene (DRG) alterations may drive susceptibility to TGCTs.To systematically evaluate the enrichment of germline pathogenic variants in the mendelian cancer predisposition DRGs in patients with TGCTs vs healthy controls.A case-control enrichment analysis was performed from January 2016 to May 2018 to screen for 48 DRGs in 205 unselected men with TGCT and 27 173 ancestry-matched cancer-free individuals from the Exome Aggregation Consortium cohort in the discovery stage. Significant findings were selectively replicated in independent cohorts of 448 unselected men with TGCTs and 442 population-matched controls, as well as 231 high-risk men with TGCTs and 3090 ancestry-matched controls. Statistical analysis took place from January to May 2018.Gene-level enrichment analysis of germline pathogenic variants in individuals with TGCTs relative to cancer-free controls.Among 205 unselected men with TGCTs (mean [SD] age, 33.04 [9.67] years), 22 pathogenic germline DRG variants, one-third of which were in CHEK2 (OMIM 604373), were identified in 20 men (9.8%; 95% CI, 6.1%-14.7%). Unselected men with TGCTs were approximately 4 times more likely to carry germline loss-of-function CHEK2 variants compared with cancer-free individuals from the Exome Aggregation Consortium cohort (odds ratio [OR], 3.87; 95% CI, 1.65-8.86; nominal P = .006; q = 0.018). Similar enrichment was also seen in an independent cohort of 448 unselected Croatian men with TGCTs (mean [SD] age, 31.98 [8.11] years) vs 442 unselected Croatian men without TGCTs (at least 50 years of age at time of sample collection) (OR, >1.4; P = .03) and 231 high-risk men with TGCTs (mean [SD] age, 31.54 [9.24] years) vs 3090 men (all older than 50 years) from the Penn Medicine Biobank (OR, 6.30; 95% CI, 2.34-17.31; P = .001). The low-penetrance CHEK2 variant (p.Ile157Thr) was found to be a Croatian founder TGCT risk variant (OR, 3.93; 95% CI, 1.53-9.95; P = .002). Individuals with the pathogenic CHEK2 loss-of-function variants developed TGCTs 6 years earlier than individuals with CHEK2 wild-type alleles (5.95 years; 95% CI, 1.48-10.42; P = .009).This multicenter case-control analysis of men with or without TGCTs provides evidence for CHEK2 as a novel moderate-penetrance TGCT susceptibility gene, with potential clinical utility. In addition to highlighting DNA-repair deficiency as a potential mechanism driving TGCT susceptibility, this analysis also provides new avenues to explore management strategies and biological investigations for high-risk individuals." @default.
• W2912138085 created "2019-02-21" @default.
• W2912138085 creator A5000094560 @default.
• W2912138085 creator A5000868104 @default.
• W2912138085 creator A5002909668 @default.
• W2912138085 creator A5013481773 @default.
• W2912138085 creator A5022357877 @default.
• W2912138085 creator A5029584334 @default.
• W2912138085 creator A5030482312 @default.
• W2912138085 creator A5032446573 @default.
• W2912138085 creator A5034775305 @default.
• W2912138085 creator A5035439869 @default.
• W2912138085 creator A5036503395 @default.
• W2912138085 creator A5039044023 @default.
• W2912138085 creator A5041987495 @default.
• W2912138085 creator A5042793052 @default.
• W2912138085 creator A5048503160 @default.
• W2912138085 creator A5054332868 @default.
• W2912138085 creator A5061602052 @default.
• W2912138085 creator A5067149045 @default.
• W2912138085 creator A5067422653 @default.
• W2912138085 creator A5072490052 @default.
• W2912138085 creator A5072952875 @default.
• W2912138085 creator A5074845302 @default.
• W2912138085 creator A5076177269 @default.
• W2912138085 creator A5080625291 @default.
• W2912138085 creator A5082890040 @default.
• W2912138085 creator A5083663241 @default.
• W2912138085 creator A5089073198 @default.
• W2912138085 creator A5091716293 @default.
• W2912138085 date "2019-04-01" @default.
• W2912138085 modified "2023-10-01" @default.
• W2912138085 title "Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (<i>CHEK2</i>) With Susceptibility to Testicular Germ Cell Tumors" @default.
• W2912138085 cites W1480741751 @default.
• W2912138085 cites W1644197353 @default.
• W2912138085 cites W1838757498 @default.
• W2912138085 cites W1964230979 @default.
• W2912138085 cites W1970255771 @default.
• W2912138085 cites W1999301366 @default.
• W2912138085 cites W2004505249 @default.
• W2912138085 cites W2011830133 @default.
• W2912138085 cites W2012718299 @default.
• W2912138085 cites W2015659776 @default.
• W2912138085 cites W2034317592 @default.
• W2912138085 cites W2036746718 @default.
• W2912138085 cites W2069732046 @default.
• W2912138085 cites W2079405556 @default.
• W2912138085 cites W2085291116 @default.
• W2912138085 cites W2116326380 @default.
• W2912138085 cites W2120942453 @default.
• W2912138085 cites W2124544785 @default.
• W2912138085 cites W2128674569 @default.
• W2912138085 cites W2161500334 @default.
• W2912138085 cites W2195144419 @default.
• W2912138085 cites W2256016639 @default.
• W2912138085 cites W2425061965 @default.
• W2912138085 cites W2427400165 @default.
• W2912138085 cites W2462985846 @default.
• W2912138085 cites W2557360435 @default.
• W2912138085 cites W2564683320 @default.
• W2912138085 cites W2624983637 @default.
• W2912138085 cites W2787174870 @default.
• W2912138085 cites W2789189552 @default.
• W2912138085 cites W4232291591 @default.
• W2912138085 cites W4292528167 @default.
• W2912138085 doi "https://doi.org/10.1001/jamaoncol.2018.6477" @default.
• W2912138085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6459214" @default.
• W2912138085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30676620" @default.
• W2912138085 hasPublicationYear "2019" @default.
• W2912138085 type Work @default.
• W2912138085 sameAs 2912138085 @default.
• W2912138085 citedByCount "36" @default.
• W2912138085 countsByYear W29121380852019 @default.
• W2912138085 countsByYear W29121380852020 @default.
• W2912138085 countsByYear W29121380852021 @default.
• W2912138085 countsByYear W29121380852022 @default.
• W2912138085 countsByYear W29121380852023 @default.
• W2912138085 crossrefType "journal-article" @default.
• W2912138085 hasAuthorship W2912138085A5000094560 @default.
• W2912138085 hasAuthorship W2912138085A5000868104 @default.
• W2912138085 hasAuthorship W2912138085A5002909668 @default.
• W2912138085 hasAuthorship W2912138085A5013481773 @default.
• W2912138085 hasAuthorship W2912138085A5022357877 @default.
• W2912138085 hasAuthorship W2912138085A5029584334 @default.
• W2912138085 hasAuthorship W2912138085A5030482312 @default.
• W2912138085 hasAuthorship W2912138085A5032446573 @default.
• W2912138085 hasAuthorship W2912138085A5034775305 @default.
• W2912138085 hasAuthorship W2912138085A5035439869 @default.
• W2912138085 hasAuthorship W2912138085A5036503395 @default.
• W2912138085 hasAuthorship W2912138085A5039044023 @default.
• W2912138085 hasAuthorship W2912138085A5041987495 @default.
• W2912138085 hasAuthorship W2912138085A5042793052 @default.
• W2912138085 hasAuthorship W2912138085A5048503160 @default.
• W2912138085 hasAuthorship W2912138085A5054332868 @default.
• W2912138085 hasAuthorship W2912138085A5061602052 @default.
• W2912138085 hasAuthorship W2912138085A5067149045 @default.
• W2912138085 hasAuthorship W2912138085A5067422653 @default.
• W2912138085 hasAuthorship W2912138085A5072490052 @default.

• next